Phase II investigation of docetaxel in pediatric patients with recurrent solid tumors: a report from the Children's Oncology Group.
about
Osteosarcoma: Current Treatment and a Collaborative Pathway to SuccessGemcitabine and docetaxel (GEMDOX) for the treatment of relapsed and refractory pediatric sarcomas.A study of docetaxel and irinotecan in children and young adults with recurrent or refractory Ewing sarcoma family of tumors.Preclinical profile of cabazitaxel.Phase II trial of ixabepilone administered daily for five days in children and young adults with refractory solid tumors: a report from the children's oncology groupEfficacy of cabazitaxel in mouse models of pediatric brain tumorsComprehensive analysis of published phase I/II clinical trials between 1990-2010 in osteosarcoma and Ewing sarcoma confirms limited outcomes and need for translational investmentOutcome of Patients With Recurrent Osteosarcoma Enrolled in Seven Phase II Trials Through Children's Cancer Group, Pediatric Oncology Group, and Children's Oncology Group: Learning From the Past to Move ForwardInitial testing (stage 1) of the anti-microtubule agents cabazitaxel and docetaxel, by the pediatric preclinical testing program.Metronomic chemotherapy and radiotherapy as salvage treatment in refractory or relapsed pediatric solid tumoursPhase I and Phase II Objective Response Rates are Correlated in Pediatric Cancer Trials: An Argument for Better Clinical Trial EfficiencyRelapsed hepatoblastoma.Advances in therapy for pediatric sarcomas.Nephronophthisis: should we target cysts or fibrosis?Blood-brain barrier, cytotoxic chemotherapies and glioblastoma.Can taxanes provide benefit in patients with CNS tumors and in pediatric patients with tumors? An update on the preclinical development of cabazitaxel.International randomized phase 2 study on the addition of docetaxel to the combination of cisplatin and 5-fluorouracil in the induction treatment for nasopharyngeal carcinoma in children and adolescents.Relapse after localized rhabdomyosarcoma: Evaluation of the efficacy of second-line chemotherapy.Medulloblastoma in children and adolescents: a systematic review of contemporary phase I and II clinical trials and biology update.Progress in the chemotherapeutic treatment of osteosarcoma
P2860
Q26797555-CD40DE54-21D1-43B7-A1C4-966C94D0AD75Q33399473-C0DDB658-0AAD-455E-8A36-4F4B3238012BQ34136875-232291B3-0FBB-48FC-B522-09ED9D9A2353Q34394251-2B51307D-87E0-4D81-A23C-4908311E3073Q34915389-470158C5-7610-4EFE-8181-A73C5AAFA833Q35788771-1404E91C-6DF3-4EE4-B2CF-6B5F9FA2A775Q35958048-5255FAC5-B2A0-4A43-94DB-4AF2A03D91B2Q36072962-734181A2-5B5B-4B56-8088-53934A9CD67DQ36592309-7A4BD0D1-6771-4BFB-9ADB-8987ED164C2DQ36989141-D0C326E0-CBA8-4700-A5E6-8C80B3806BCDQ37048013-C551248C-D380-4C70-BEAB-EB19B8FBF27BQ38014792-7E002233-7867-4701-884C-1E810B368792Q38217354-2F355293-B001-448C-A3E8-49B0071D3DD4Q38556258-6126916A-8C4B-4131-A776-D3528276B3C8Q38867048-F9599DC6-1F0A-497B-9E54-E4DED899D24BQ39131399-EBD876C4-70A5-4C6F-9759-CE25EA0C8605Q41051506-D84C05D8-87DB-4CFC-8670-92EF7CDFBE1AQ41607004-ECA6D44F-EF38-4FD4-A976-996D0CE01B2AQ47133403-CEAD9CC2-3532-49A6-A035-F598FDFEA1D0Q58572917-23CDF9ED-EFE6-49A1-91E5-C8DC430A75E3
P2860
Phase II investigation of docetaxel in pediatric patients with recurrent solid tumors: a report from the Children's Oncology Group.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Phase II investigation of doce ...... the Children's Oncology Group.
@en
Phase II investigation of doce ...... the Children's Oncology Group.
@nl
type
label
Phase II investigation of doce ...... the Children's Oncology Group.
@en
Phase II investigation of doce ...... the Children's Oncology Group.
@nl
prefLabel
Phase II investigation of doce ...... the Children's Oncology Group.
@en
Phase II investigation of doce ...... the Children's Oncology Group.
@nl
P2093
P356
P1433
P1476
Phase II investigation of doce ...... the Children's Oncology Group.
@en
P2093
Children's Oncology Group
Gregory Reaman
John Strain
Judith Sato
Mark Krailo
Philip Monteleone
Rebecca Byrd
Rose Dunaway
Ted Zwerdling
Zhengjia Chen
P304
P356
10.1002/CNCR.21779
P407
P577
2006-04-01T00:00:00Z